Powder represents 72.8% within the form segment and ≥99.5% accounts for 99.5% of the purity grade category in 2026. The telmisartan market was valued at USD 109.7 million in 2025, is projected to reach USD 118.6 million by 2036 and is forecast to post a 0.7% CAGR between 2026 and 2036.